TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.

Dung T Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.